Related Experiment Video
Updated: Mar 21, 2026

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
Published on: November 21, 2023
A genetically stable GFP reporter virus platform for contemporary Chinese PRRSV-1 and its use in fluorescence
Yiting Chen1, Xindong Wang1, Keyi Liu1
1Laboratory of Animal Infectious Diseases and Molecular Immunology, College of Animal Science and Technology, Guangxi University, Nanning, 530005, China.
Abstract:
The rapid dissemination of phylogenetically diverse porcine reproductive and respiratory syndrome virus type 1 (PRRSV-1) strains in China necessitates advanced research tools tailored to contemporary isolates. To address the scarcity of such resources, we developed a reverse-genetics platform for the prevalent Chinese PRRSV-1 strain GXFS20220129. A full-length infectious cDNA clone was constructed and used to rescue replication-competent virus (rGXFS/F3/ic), Its growth kinetics were showed slightly attenuated compared to the parental strain but maintained a similar overall growth pattern. Utilizing this system, we generated recombinant reporter viruses expressing green fluorescent protein (GFP), driven by a transcription regulatory sequence (TRS) from either a homologous PRRSV-1 or a heterologous PRRSV-2 source, inserted at the ORF1b-ORF2 junction. The virus incorporating the heterologous PRRSV-2 TRS6 element exhibited significantly stronger GFP and viral protein expression, indicating enhanced transcriptional activity. This optimized reporter virus, designated rGXFS-GFP, demonstrated stable replication kinetics and plaque morphology similar to the parental clone and maintained genetic stability over ten serial passages. Furthermore, rGXFS-GFP was successfully applied in a fluorescence-based virus neutralization assay, providing a direct and quantitative readout for neutralizing antibodies. This study establishes a vital reverse-genetics and reporter virus system for a circulating PRRSV-1 strain, offering a robust tool to accelerate research into viral biology, vaccine efficacy, and antiviral strategies against this emerging threat.

